Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Prof ihab ahmed

Cairo University, Egypt

Title: laparoscopic proximal gastrectomy in gastro esophageal junction tumors

Biography

Biography: Prof ihab ahmed

Abstract

Background:

For Siewert  type I and II gastroesophageal junction tumor (GEJ) laparoscopic proximal gastrectomy can be performed. It is associated with several perioperative benefits compared with open proximal gastrectomy. The use of laparoscopic proximal gastrectomy (LPG) has become an increasingly popular approach for select tumors

Methods

We describe our technique for  LPG, including the preoperative work-up, illustrated images of the main principle  steps of the surgery, and our postoperative course.

Results

Thirteen pts (nine male, four female) with type I ,II  (GEJ) adenocarcinoma had laparoscopic radical proximal gastrectomy and D2 lymphadenectomy . All of our patient received neoadjuvant chemotherapy, eleven patients had intrathoracic anastomosis through mini thoracotomy ( two hand sewn end to end anastomoses and the other 9 patient end to side  using circular stapler), two patients with intrathoracic anastomosis had flap and wrap technique, two patients had thoracoscopic esophageal and mediastinal lymph node  dissection with cervical anastomosis

The mean blood loss 80ml, No cases was converted to open .The mean operative time  250 minute Average LN retrieved 19-25, No sever complication such as leakage, stenosis, pancreatic fistula ,or intra-abdominal abscess were reported. Only One patient presented with empyema 1.5 month after discharge that was managed conservatively.

Conclusion

For carefully selected patients, LPG in GEJ tumour type I nad II  is a safe  and reasonable alternative for open technique , which is associated with similar oncologic outcomes and low morbidity. It showed less blood loss, respiratory infections, with similar 1- and 3-year survival rates.